Dashenlin
Dashenlin
The company takes the development of pharmacy chain as the foundation of its business
Dashenlin Pharmaceutical Group Co. is a group enterprise integrating pharmaceutical production and sales. The company takes the development of pharmacy chain as the foundation of its business, and after many years of development, at the end of 2015, there were nearly 2,000 directly operated chain stores and nearly 18,000 employees.
- All
- News
- Analysis
- Research
Briefing Sep 30, 2021 02:41 PM
· Healthcare
AstraZeneca acquires Caelum Biosciences overweight rare diseases business
Briefing Sep 27, 2021 11:57 AM
· Healthcare
Triarm therapeutics completed a round of financing of US $60 million
In depth
Healthcare
Backed up by Rich Dad – What’s Next for Ping An Good Doctor?
Having a rich dad can help with capital and connections when a company is at the ‘infant’ stage. But being independent comes sooner or later. When shall that be for Ping An Good Doctor? Or will it not come at all?
Aug 27, 2020 01:02 PM
Briefing Aug 31, 2021 05:29 PM
· Healthcare
Dashi pharmaceutical completed a round of financing of nearly 100 million yuan
Briefing Aug 24, 2021 06:15 PM
· Healthcare
Ping An Health's revenue in the first half of the year was RMB 3.818 billion, and the four scenarios of "one person and one doctor" were constructed
Research
Consumer Staples, Technology, HealthcareWIA2020 | Rising Tech Stars 2020: Global & China's 100
Dec 09, 2020 09:57 AM
Dec 09, 2020 09:39 AM
Research
Consumer Discretionary, Consumer Staples, IndustrialsTech for Global, Globalization Footprints of the Established and the New
May 29, 2020 08:30 PM
Research
Consumer Discretionary, Consumer Staples, IndustrialsLow-Carbon Industry Expansion - Key Studies From Chinese Companies
May 28, 2020 12:40 PM
Briefing Aug 14, 2021 12:18 AM
· Healthcare
Seven months after the launch, Youli Meiya won the angel round of investment
Briefing Aug 04, 2021 04:54 PM
· Healthcare
1. The strategic cooperation between pharmaceutical network and Bayer pharmaceutical has been upgraded to explore and innovate the digital patient service model
Briefing Jul 20, 2021 10:19 AM
· Healthcare
With tens of millions of angel rounds of investment, we are committed to semiconductor technology enabling biomedical industry
Briefing Jul 02, 2021 02:10 PM
· Healthcare
Li Jidian: the production capacity of next year has been fully reserved, and it can be listed before the end of the year
Briefing May 27, 2021 02:02 AM
· Healthcare
Alibaba Health Information publishes rather poor annual figures
Insight
Briefing May 21, 2021 12:17 AM
· Healthcare
Medtech company So-Young International with surprisingly good growth figures
Briefing Feb 09, 2021 08:39 AM
· Healthcare
Tens of millions of strategic investment from CommScope
Briefing Feb 07, 2021 06:00 PM
· Healthcare
Shenzhi technology completed tens of millions of RMB B + round financing
Briefing Feb 01, 2021 02:41 PM
· Healthcare
Bh009 new drug project independently researched and developed by Beihai biological Co., Ltd. was approved by China's clinical trials
See more
Related Companies
EqualOcean Analysis
- Digital Health on a Rise: JD Health Stocks Spike 70% on First Trading Day
- Ding Dang Kuai Yao: A Chinese E-Commercial Way to Run a Pharmacy
- Black Swans and Breakthroughs: China's Top 50 Innovative Public Firms in 2020
- Ali Health Aims Higher with Rebranding and New Strategies
- More Room for the Medical Device Market to Grow in China
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.